Nabla Bio is a Cambridge, Massachusetts AI drug-design company that combines generative molecular modeling with integrated wet-lab testing to develop antibody and other protein therapeutics.
Daily open opportunities, newly observed postings, hiring breadth, and normalized monthly compensation for jobs in this pillar.
As of 2026-09-23
Distinct employers
+3 vs prior week
7 days vs previous 7 days
Open roles, employers, and newly listed jobs by day
Earlier open counts are estimated from observation dates. Offline postings are never inferred open for more than 90 days; new daily samples are exact snapshots.
Nabla Bio is a Cambridge, Massachusetts AI drug-design company that combines generative molecular modeling with integrated wet-lab testing to develop antibody and other protein therapeutics.
Funding history
Its JAM (Joint Atomic Model) platform uses protein sequence, structure, and Nabla-generated experimental measurements for de novo biologics design, affinity/developability optimization, and multispecific therapeutic design, with a focus on difficult targets such as GPCRs, ion channels, and transporters.
Its JAM (Joint Atomic Model) platform uses protein sequence, structure, and Nabla-generated experimental measurements for de novo biologics design, affinity/developability optimization, and multispecific therapeutic design, with a focus on difficult targets such as GPCRs, ion channels, and transporters.
3 open jobs
Nabla Bio·1 day ago
Nabla Bio is a Cambridge, Massachusetts AI drug-design company that combines generative molecular modeling with integrated wet-lab testing to develop antibody and other protein therapeutics.
Nabla Bio·1 day ago
Nabla Bio is a Cambridge, Massachusetts AI drug-design company that combines generative molecular modeling with integrated wet-lab testing to develop antibody and other protein therapeutics.
Nabla Bio·1 day ago
Nabla Bio is a Cambridge, Massachusetts AI drug-design company that combines generative molecular modeling with integrated wet-lab testing to develop antibody and other protein therapeutics.
